Myriad Genetics is a leader in genetic testing and precision medicine, dedicated to advancing health and well-being for all by unlocking the power of genetic science. With over 30 years of expertise, the company provides actionable insights through innovative tests that help individuals take control of their health and enable healthcare providers to better detect, treat, and prevent diseases. Myriad’s focus areas include hereditary cancer risk, reproductive health, oncology, urology, and mental health. Notable achievements include discovering the BRCA1/2 genes, developing the first hereditary breast and ovarian cancer test (BRACAnalysis), and creating personalized risk assessments like MyRisk with RiskScore®.